Analysis of the Distribution and Drug Resistance of Pathogens in Patients with Urinary Tract Infection in the Eastern Chongming Area of Shanghai from 2018 to 2020

References

• Wagenlehner FME, Bjerklund Johansen TE, Cai T., et al. Epidemiology, definition and treatment of complicated urinary tract infections. Nat Rev Urol. 2020;17(10):586–600. doi:10.1038/s41585-020-0362-4
   PubMed Web of Science ®Google Scholar
• Christaki E, Marcou M, Tofarides A. Antimicrobial resistance in bacteria: mechanisms, evolution, and persistence. J Mol Evol. 2020;88(1):26–40. doi:10.1007/s00239-019-09914-3
   PubMed Web of Science ®Google Scholar
• Chokshi A, Sifri Z, Cennimo D, et al. Global contributors to antibiotic resistance. J Glob Infect Dis. 2019;11(1):36–42. doi:10.4103/jgid.jgid_110_18
   PubMed Web of Science ®Google Scholar
• Anderson M, Schulze K, Cassini A, et al. A governance framework for development and assessment of national action plans on antimicrobial resistance. Lancet Infect Dis. 2019;19(11):e371–e384. doi:10.1016/S1473-3099(19)30415-3
   PubMed Web of Science ®Google Scholar
• Cassini A, Högberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66. doi:10.1016/S1473-3099(18)30605-4
   PubMed Web of Science ®Google Scholar
• Gajdács M, Ábrók M, Lázár A, et al. Increasing relevance of Gram-positive cocci in urinary tract infections: a 10-year analysis of their prevalence and resistance trends. Sci Rep. 2020;10(1):17658. doi:10.1038/s41598-020-74834-y
   PubMed Web of Science ®Google Scholar
• Navon-Venezia S, Kondratyeva K, Carattoli A. Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol Rev. 2017;41(3):252–275. doi:10.1093/femsre/fux013
   PubMed Web of Science ®Google Scholar
• Raeispour M, Ranjbar R. Antibiotic resistance, virulence factors and genotyping of Uropathogenic Escherichia coli strains. Antimicrob Resist Infect Control. 2018;7(1):118. doi:10.1186/s13756-018-0411-4
   Web of Science ®Google Scholar
• Khonsari MS, Behzadi P, Foroohi F. The prevalence of type 3 fimbriae in Uropathogenic Escherichia coli isolated from clinical urine samples. Meta Gene. 2021;28:100881. doi:10.1016/j.mgene.2021.100881
   Web of Science ®Google Scholar
• Hozzari A, Behzadi P, Kerishchi Khiabani P, et al. Clinical cases, drug resistance, and virulence genes profiling in Uropathogenic Escherichia coli. J Appl Genet. 2020;61(2):265–273. doi:10.1007/s13353-020-00542-y
   PubMed Web of Science ®Google Scholar
• Behzadi P. Classical chaperone-usher (CU) adhesive fimbriome: uropathogenic Escherichia coli (UPEC) and urinary tract infections (UTIs). Folia Microbiol (Praha). 2020;65(1):45–65. doi:10.1007/s12223-019-00719-x
   PubMed Web of Science ®Google Scholar
• Partridge SR, Kwong SM, Firth N, et al. Mobile genetic elements associated with antimicrobial resistance. Clin Microbiol Rev. 2018;31(4):e00088–17. doi:10.1128/CMR.00088-17
   PubMed Web of Science ®Google Scholar
• Rozwadowski M, Gawel D. Molecular Factors and Mechanisms Driving Multidrug Resistance in Uropathogenic Escherichia coli —An Update. Genes. 2022;13(8):1397. doi:10.3390/genes13081397
   Web of Science ®Google Scholar
• Alvarez-Uria G, Gandra S, Mandal S, et al. Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae. Int J Infect Dis. 2018;68:50–53. doi:10.1016/j.ijid.2018.01.011
   PubMed Web of Science ®Google Scholar
• Huang L, Huang C, Yan Y, et al. Urinary tract infection etiological profiles and antibiotic resistance patterns varied among different age categories: a retrospective study from a tertiary general hospital during a 12-year period. Front Microbiol. 2022;12:813145. doi:10.3389/fmicb.2021.813145
   Web of Science ®Google Scholar
• Ulrich N, Vonberg R-P, Gastmeier P. Outbreaks caused by vancomycin-resistant Enterococcus faecium in hematology and oncology departments: a systematic review. Heliyon. 2017;3(12):e00473. doi:10.1016/j.heliyon.2017.e00473
   Web of Science ®Google Scholar
• Bender JK, Hermes J, Zabel LT, et al. Controlling an unprecedented outbreak with vancomycin-resistant Enterococcus faecium in Germany, October 2015 to November 2019. Microorganisms. 2022;10(8):1603. doi:10.3390/microorganisms10081603
   Web of Science ®Google Scholar
• Gast KB, van Oudheusden AJG, Murk JL, et al. Successful containment of two vancomycin-resistant Enterococcus faecium (VRE) outbreaks in a Dutch teaching hospital using environmental sampling and whole-genome sequencing. J Hosp Infect. 2021;111:132–139. doi:10.1016/j.jhin.2021.02.007
   Web of Science ®Google Scholar
• Zhou W, Zhou H, Sun Y, et al. Characterization of clinical enterococci isolates, focusing on the vancomycin-resistant enterococci in a tertiary hospital in China: based on the data from 2013 to 2018. BMC Infect Dis. 2020;20(1):356. doi:10.1186/s12879-020-05078-4
   PubMed Web of Science ®Google Scholar
• Ripabelli G, Lucia. SM, Scutellà M, Felice V, Manuela T. Escherichia coli Carbapenem-Resistant KPC- and TEM-Producing ST131 Isolated from a Hospitalized Patient with Urinary Tract Infection: first Isolation in Molise Region, Central Italy, July 2018. Microb Drug Resist. 2020;26(1):38–45. doi:10.1089/mdr.2019.0085
   Web of Science ®Google Scholar
• Bilal H, Khan MN, Rehman T, et al. Antibiotic resistance in Pakistan: a systematic review of past decade. BMC Infect Dis. 2021;21(1):244. doi:10.1186/s12879-021-05906-1
   PubMed Web of Science ®Google Scholar
• Tian L, Zhang Z, Sun Z. Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998-2017). Antimicrob Resist Infect Control. 2019;8(1):86. doi:10.1186/s13756-019-0545-z
   PubMed Web of Science ®Google Scholar
• Tandogdu Z, Wagenlehner FM. Global epidemiology of urinary tract infections. Curr Opin Infect Dis. 2016;29(1):73–79. doi:10.1097/QCO.0000000000000228
   PubMed Web of Science ®Google Scholar
• Larramendy S, Deglaire V, Dusollier P, et al. Risk Factors of Extended-Spectrum Beta-Lactamases-Producing Escherichia coli Community Acquired Urinary Tract Infections: a Systematic Review. Infect Drug Resist. 2020;13:3945–3955. doi:10.2147/IDR.S269033
   Web of Science ®Google Scholar
• Hofer U. Novel metallo-β-lactamase inhibitors. Nat Rev Microbiol. 2022;20(3):125.
   Google Scholar
• Cusini A, Herren D, Bütikofer L, et al. Intra-hospital differences in antibiotic use correlate with antimicrobial resistance rate in Escherichia coli and Klebsiella pneumoniae: a retrospective observational study. Antimicrob Resist Infect Control. 2018;7(1):89. doi:10.1186/s13756-018-0387-0
   Web of Science ®Google Scholar
• Yang Q, Zhang H, Wang Y, et al. Antimicrobial susceptibilities of aerobic and facultative gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014. BMC Infect Dis. 2017;17(1):192. doi:10.1186/s12879-017-2296-x
   Web of Science ®Google Scholar
• Jia P, Zhu Y, Li X, et al. High prevalence of extended-spectrum beta-lactamases in Escherichia coli strains collected from strictly defined community-acquired urinary tract infections in adults in China: a multicenter prospective clinical microbiological and molecular study. Front Microbiol. 2021;12:663033. doi:10.3389/fmicb.2021.663033
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics. Quinolone and fluoroquinolone Article-31 referral; 2019. Available from: https://www.ema.europa.eu/en/documents/referral/quinolone-fluoroquinolone-article-31-referral-disabling-potentially-permanent-side-effects-lead_en.pdf. Accessed October 26, 2022.
   Google Scholar
• Canouï E, Kerneis S, Morand P, et al. Oral levofloxacin: population pharmacokinetics model and pharmacodynamics study in bone and joint infections. J Antimicrob Chemother. 2022;77(5):1344–1352. doi:10.1093/jac/dkac031
   Web of Science ®Google Scholar
• Cojutti PG, Ramos-Martin V, Schiavon I, et al. Population pharmacokinetics and pharmacodynamics of levofloxacin in acutely hospitalized older patients with various degrees of renal function. Antimicrob Agents Chemother. 2017;61(3). doi:10.1128/AAC.02134-16
   Web of Science ®Google Scholar
• Kot B, Wicha J, Grużewska A, et al. Virulence factors, biofilm-forming ability, and antimicrobial resistance of urinary Escherichia coli strains isolated from hospitalized patients. Turk J Med Sci. 2016;46(6):1908–1914. doi:10.3906/sag-1508-105
   Web of Science ®Google Scholar
• Prakash D, Saxena RS. Distribution and antimicrobial susceptibility pattern of bacterial pathogens causing urinary tract infection in urban community of Meerut city, India. ISRN Microbiol. 2013;2013:749629. doi:10.1155/2013/749629
   PubMedGoogle Scholar
• Chapelle C, Gaborit B, Dumont R, et al. Treatment of UTIs Due to Klebsiella pneumoniae Carbapenemase-Producers: how to Use New Antibiotic Drugs? A Narrative Review. Antibiotics. 2021;10(11). doi:10.3390/antibiotics10111332
   Web of Science ®Google Scholar
• Yin D, Dong D, Li K, et al. Clonal dissemination of OXA-232 carbapenemase-producing Klebsiella pneumoniae in neonates. Antimicrob Agents Chemother. 2017;61(8). doi:10.1128/AAC.00385-17
   Web of Science ®Google Scholar
• Di Tella D, Tamburro M, Guerrizio G, et al. Molecular Epidemiological Insights into Colistin-Resistant and Carbapenemases-Producing Clinical Klebsiella pneumoniae Isolates. Infect Drug Resist. 2019;12:3783–3795. doi:10.2147/IDR.S226416
   PubMed Web of Science ®Google Scholar
• Wang N, Zhan M, Liu J, et al. Prevalence of carbapenem-resistant Klebsiella pneumoniae infection in a Northern Province in China: clinical characteristics, drug resistance, and geographic distribution. Infect Drug Resist. 2022;15:569–579. doi:10.2147/IDR.S347343
   PubMed Web of Science ®Google Scholar
• Lou T, Du X, Zhang P, et al. Risk factors for infection and mortality caused by carbapenem-resistant Klebsiella pneumoniae: a large multicentre case-control and cohort study. J Infect. 2022;84(5):637–647. doi:10.1016/j.jinf.2022.03.010
   PubMed Web of Science ®Google Scholar
• Li J, Li Y, Song N, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection: a meta-analysis. J Glob Antimicrob Resist. 2020;21:306–313. doi:10.1016/j.jgar.2019.09.006
   PubMed Web of Science ®Google Scholar
• Shrestha LB, Baral R, Khanal B. Comparative study of antimicrobial resistance and biofilm formation among Gram-positive uropathogens isolated from community-acquired urinary tract infections and catheter-associated urinary tract infections. Infect Drug Resist. 2019;12:957–963. doi:10.2147/IDR.S200988
   Web of Science ®Google Scholar
• Wong CKM, Kung K, Au-Doung PLW, et al. Antibiotic resistance rates and physician antibiotic prescription patterns of uncomplicated urinary tract infections in southern Chinese primary care. PLoS One. 2017;12(5):e0177266. doi:10.1371/journal.pone.0177266
   Web of Science ®Google Scholar
• Gao W, Howden BP, Stinear TP. Evolution of virulence in Enterococcus faecium, a hospital-adapted opportunistic pathogen. Curr Opin Microbiol. 2018;41:76–82. doi:10.1016/j.mib.2017.11.030
   PubMed Web of Science ®Google Scholar